StockNews.com started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note published on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock.
Neptune Wellness Solutions Stock Performance
Shares of NASDAQ:NEPT opened at $0.51 on Thursday. The company has a quick ratio of 0.38, a current ratio of 0.87 and a debt-to-equity ratio of 0.94. Neptune Wellness Solutions has a 52-week low of $0.23 and a 52-week high of $10.96. The company has a 50 day moving average of $0.63 and a two-hundred day moving average of $0.98.
Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) last released its earnings results on Friday, December 16th. The biotechnology company reported ($0.79) EPS for the quarter. The business had revenue of $11.99 million for the quarter. Neptune Wellness Solutions had a negative net margin of 149.78% and a negative return on equity of 75.30%. Sell-side analysts predict that Neptune Wellness Solutions will post -11.35 EPS for the current fiscal year.
Hedge Funds Weigh In On Neptune Wellness Solutions
Neptune Wellness Solutions Company Profile
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.